The present invention provides novel compounds of Formula (I) and (I(a)), or the pharmaceutically acceptable salt thereof; methods for treating neurological disorders and neurodegenerative diseases, particularly pain and migraine, comprising administering a compound of Formula (I) or Formula (I(a)); and processes for ...

Compounds of the general formula (I) are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system.

A compund according to formula II and the plumma ceutically acceptable salt thereof and the method of treating cancer in a patient in need thereof by administration of salt compound.

An apparatus for delivering a pharmaceutical liquid to a patient includes an outer casing; a needle cassette housed in the casing and containing a plurality of mutually parallel drug injection needles; a drug cartridge housed in the casing, containing a liquid and including a sealable aperture for accessing the liqu...

The present invention relates to cycloalkyl-benzopyran compound andpharmaceutical composition thereof and processes for the preparation of thesame. The compounds of the present invention are useful as Estrogen Receptorbeta agonists. Such agonists are useful for the treating Estrogen Recepto...

The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.